Category Archives: Pr Newswire

Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has entered into a definitive agreement with a single healthcare-dedicated institutional investor for the issuance and sale of an aggregate of 5,853,659 shares of its common stock (or common stock equivalents […]

Inspire Medical Systems, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024

MINNEAPOLIS, July 02, 2024 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2024 after the close of trading on Tuesday, August 6. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business […]

Dr. Gabriele Weichert takes the helm as President of the Canadian Dermatology Association

OTTAWA, July 02, 2024 (GLOBE NEWSWIRE) — The Canadian Dermatology Association (CDA) is proud to announce the appointment of Dr. Gabriele Weichert as CDA President, effective June 28, 2024. Dr. Gabriele Weichert is the medical director at SkinCareWest, a medical and surgical Dermatology clinic in Nanaimo BC. She has been in practice for 20 years. […]

Beko achieves 44th place on TIME’s inaugural list of the world’s most sustainable companies

Ranked among the top 500 global companies leading the way in sustainability. Recognized for its commitment to eco-friendly practices and net-zero goals. Highest-ranking home appliance company on the list. ISTANBUL, July 2, 2024 /PRNewswire/ — Global household appliance manufacturer Beko has been recognized for its commitment to sustainability, securing the 44th spot on TIME Magazine […]

Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease

SHANGHAI, July 2, 2024 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the successful initiation and first two patients enrollment for its global multicenter clinical study exploring the percutaneous pulmonary artery denervation (PADN) treatment for pulmonary hypertension associated with left heart disease. This landmark […]

Montrose Environmental Group Releases 2023 Sustainability Report Executive Summary

LITTLE ROCK, Ark., July 2, 2024 /PRNewswire/ — Montrose Environmental Group, Inc. (“Montrose” or “the Company”) (NYSE: MEG), a high-growth global environmental solutions company, today released its 2023 Sustainability Report Executive Summary highlighting key accomplishments in the Company’s sustainability journey and celebrating innovations creating impact across the globe.   The 2023 Sustainability Report Executive Summary focuses […]

RBW EV Cars Announces New Guest Experience with Le Manoir aux Quat’Saisons

New Business Relationship Blends Sustainability with the Quintessential British Experience by Offering Guests of Le Manoir an Eco-Friendly Tour Courtesy of RBW’s EV-Powered Classic Sports Car LONDON, July 2, 2024 /PRNewswire/ — RBW EV Cars – the UK’s only EV manufacturer of new, hand-crafted British classic sports cars, today announced that Le Manoir aux Quat’Saisons, a […]

Hisense Partners with Safe-Hub Berlin to Create Inclusive Watch Parties for UEFA EURO 2024™

QINGDAO, China, July 2, 2024 /PRNewswire/ — Hisense, a global leader in consumer electronics and appliances, today announced a partnership with Safe-Hub Berlin, to unite a diverse community of young people through the power of football during the UEFA EURO 2024™. As an official partner of UEFA EURO 2024™, Hisense will support a series of […]

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, July 01, 2024 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that on July 1, 2024, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of […]

Alvotech Issues New Shares to Holders of Convertible Bonds

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued new shares to holders of subordinated convertible bonds, originally issued by Alvotech on November 16, 2022, and December 20, 2022, with maturity on December 20, 2025 (the “Convertible Bonds”). Today, Alvotech issued 22,073,578 new […]